Virus News and Research

Latest Virus News and Research

Kelley study to consider HPV treatment decisions

Dena S. Cox, professor of marketing and faculty fellow at the Kelley School of Business Indianapolis, has received a $99,600, two-year research grant from Merck to study factors influencing young women’s adoption of the human papillomavirus (HPV) vaccine.

21 Sep 2011

New FDA-approved antiviral drugs offer treatment hope for hepatitis C

The Methodist Hospital in Houston is excited to share significant news for patients who need treatment for hepatitis C genotype 1, a viral infection that causes liver inflammation that can lead to diminished liver function or symptoms for liver failure.

21 Sep 2011

Bird flu strikes Eastern India yet again as culling operations begin

On Tuesday, the federal government in India announced that it had ordered poultry farms in the eastern part of the country to cull chickens and destroy eggs to rein in an new outbreak of bird flu.

21 Sep 2011

Antivirals from shark cartilage compound squalamine

A unique compound originally isolated from sharks could prove to be a promising treatment for hepatitis B and C and other viral diseases, researchers say. Known as squalamine, the drug has not yet been tested as an antiviral agent in humans, but it has been given to hundreds of people enrolled in clinical trials designed to test its usefulness for other conditions. Researchers say they hope to begin human trials to test the compound’s antiviral activity within the next year.

21 Sep 2011

Polio in China

Polio has spread to China for the first time since 1999 after being imported from Pakistan, the World Health Organization (WHO) has confirmed. It said a strain of polio (WPV1) found in China was genetically linked with the type now circulating in Pakistan. At least seven cases have now been confirmed in China's western Xinjiang province, which borders Pakistan.

21 Sep 2011

Polio in Pakistan prompts India to implement border crossing vaccination campaign

Officials in Pakistan on Monday "announced targeted, three-day anti-polio campaigns in affected areas, which include Karachi and districts in the Federally Administered Tribal Areas," the Wall Street Journal's "India Real Time" blog reports.

21 Sep 2011

Viewpoints: Mixing politics and deficit cutting; transparency in health care; doctors' salaries

On the spending side, the president's plan takes a sensible approach toward saving money in Medicare and Medicaid. More than 90 percent of the $248 billion in Medicare cuts over 10 years would come from reducing payments to drug companies and health care providers that are unnecessarily high.

21 Sep 2011

Scientists discover crucial connection in skin formation

Skin is the body's armor, protecting us from disease agents, injury, excessive water loss, and cold and heat. Yet mutations in a single gene, the gene for the protein p63, cause numerous diseases and malformations of the uppermost layer of skin - the epidermis - and other tissues. In the epidermis, these range from skin cancers to dysplasias that cause cracking, bleeding, infection, and discoloration.

21 Sep 2011

Roundup: HIPAA enforcement; Brownback blasted for rejecting federal grant; nurses strike in Calif.

Only two state attorneys general have pursued the authority Congress gave them two years ago to prosecute privacy and security breaches of health information - despite training from federal agencies and a consensus among privacy groups that enforcement needs to improve. The expansion of jurisdiction to state attorneys general was awarded in concert with a $27 billion stimulus program initiated in 2009 to reward health care providers for switching from print to computerized health records.

21 Sep 2011

Gilead’s Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective

Gilead Sciences, Inc. today announced that the second pivotal Phase 3 clinical trial of its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, being evaluated for HIV-1 infection in treatment-naïve patients, met its primary objective of non-inferiority at week 48 as compared to ritonavir-boosted atazanavir plus Truvada.

20 Sep 2011

Liposomes block HIV infection in early tests

Could engineered fatty particles help prevent AIDS? Liposomes block HIV infection in early tests; could be a cost-effective preventive for developing countries

20 Sep 2011

Autopsy study reveals earliest 1918 pandemic influenza cases

Examination of lung tissue and other autopsy material from 68 American soldiers who died of respiratory infections in 1918 has revealed that the influenza virus that eventually killed 50 million people worldwide was circulating in the United States at least four months before the 1918 influenza reached pandemic levels that fall.

20 Sep 2011

New UTHealth toll-free helpline for pregnant women to avoid dangerous medications

A new toll-free helpline developed to help pregnant women avoid medications and other substances that can cause birth defects has been launched by The University of Texas Health Science Center at Houston (UTHealth) for the Texas Department of State Health Services.

20 Sep 2011

Online gamers decipher 3D molecular structure that may help AIDS research

Online gamers have deciphered the structure of an enzyme of an AIDS-like virus that had thwarted scientists for a decade. The exploit was published in the journal, Nature Structural & Molecular Biology, where - exceptionally in scientific publishing - both gamers and researchers are honored as co-authors.

19 Sep 2011

NanoViricides acquires light industrial building for laboratory facilities and cGMP production

NanoViricides, Inc. announced that Inno-Haven LLC has completed acquisition of a light industrial building. The Company anticipates that it will be leasing a portion of this space, in the near future, for laboratory facilities and cGMP production of its nanoviricides® drug candidates against various viral diseases.

19 Sep 2011

Inhibitex initiates INX-189 combination Phase 2 trial in HCV-infected genotype 2/3 patients

Inhibitex, Inc., announced today that it has recently commenced dosing in a 90-patient randomized, placebo controlled, treatment guided, Phase 2 clinical trial to evaluate the safety, tolerability and antiviral activity of INX-189 in combination with pegylated interferon and ribavirin in chronic HCV-infected genotype 2 and 3 treatment naïve patients.

19 Sep 2011

Gamers solve molecular structure of retrovirus enzyme

Gamers have solved the structure of a retrovirus enzyme whose configuration had stumped scientists for more than a decade. The gamers achieved their discovery by playing Foldit, an online game that allows players to collaborate and compete in predicting the structure of protein molecules.

19 Sep 2011

Emergency mosquito control operations in flood affected Pennsylvania counties

The Department of Environmental Protection announced today it will begin conducting emergency mosquito control operations in 18 counties affected by flooding.

17 Sep 2011

Bioethicists up the ante in Bachmann's HPV brouhaha

Since Monday's GOP presidential primary debate, Michele Bachmann, a Republican candidate, has been under the microscope for criticizing fellow GOP hopeful Rick Perry for his policy in Texas requiring girls to get the Gardisil vaccine against HPV. Now, two bioethicists have offered cash prizes if she can prove a claim she made about the vaccine's link to mental retardation.

17 Sep 2011

Afghanistan facing challenges in effort to eradicate polio by end of 2012

"Afghanistan is intensifying efforts to eradicate polio by the end of next year, but security remains a major challenge especially in the southern provinces where the virus is localized, says" Arshad Quddus, head of the WHO polio program in Afghanistan, IRIN reports.

17 Sep 2011

Virus News and Research

Latest Virus News and Research

Kelley study to consider HPV treatment decisions

New FDA-approved antiviral drugs offer treatment hope for hepatitis C

Bird flu strikes Eastern India yet again as culling operations begin

Antivirals from shark cartilage compound squalamine

Polio in China

Polio in Pakistan prompts India to implement border crossing vaccination campaign

Viewpoints: Mixing politics and deficit cutting; transparency in health care; doctors' salaries

Scientists discover crucial connection in skin formation

Roundup: HIPAA enforcement; Brownback blasted for rejecting federal grant; nurses strike in Calif.

Gilead’s Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective

Liposomes block HIV infection in early tests

Autopsy study reveals earliest 1918 pandemic influenza cases

New UTHealth toll-free helpline for pregnant women to avoid dangerous medications

Online gamers decipher 3D molecular structure that may help AIDS research

NanoViricides acquires light industrial building for laboratory facilities and cGMP production

Inhibitex initiates INX-189 combination Phase 2 trial in HCV-infected genotype 2/3 patients

Gamers solve molecular structure of retrovirus enzyme

Emergency mosquito control operations in flood affected Pennsylvania counties

Bioethicists up the ante in Bachmann's HPV brouhaha

Afghanistan facing challenges in effort to eradicate polio by end of 2012

A new way of characterising biomolecules eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in